Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Hospital of the University of Pennsylvania
Filadelfia, Estados UnidosPublications en collaboration avec des chercheurs de Hospital of the University of Pennsylvania (1)
2017
-
Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody
Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936